Devin Wenig, Director at NASTECH PHARMACEUTICAL CO INC (NSTK), sold 3,000 shares at $13.84 ($42K) on 2007-09-04, disclosed to the SEC on 2007-09-05.
Scheduled sale ($42k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.76 | 200 | $3K | 6.6% |
| 2 | $13.80 | 300 | $4K | 9.9% |
| 3 | $13.84 | 200 | $3K | 6.6% |
| 4 | $13.85 | 800 | $11K | 26.6% |
| 5 | $13.88 | 200 | $3K | 6.7% |
| 6 | $13.90 | 500 |
| $7K |
| 16.7% |
| 7 | $13.95 | 400 | $6K | 13.4% |
| 8 | $14.00 | 200 | $3K | 6.7% |
| 9 | $14.15 | 200 | $3K | 6.8% |
| Total | $13.89 avg | 3,000 | $42K | 100% |
| Filing → |
| EBAY | SELL | 2019-07-03 | $398K | — | Filing → |
| EBAY | SELL | 2018-02-08 | $11.5M | — | Filing → |
| EBAY | SELL | 2013-10-31 | $2.4M | — | Filing → |